EpiCept pushing for drug approval
-
- May
- 27
EpiCept Corp., a pharmaceutical company in Eastview, said today it has provided regulators in Europe with a “comprehensive dossier” stating why the regulators should re-consider the company’s application to market Ceplene, a drug to prevent certain leukemia patients from suffering a relapse.
The company said that in recent months a number of medical experts have recommended the approval of Ceplene.
In March, the European Committee for Medicinal Products for Human Use issued a negative opinion on Ceplene. EpiCept has asked that the decision be reviewed.
This entry was posted
on Tuesday, May 27th, 2008 at 1:14 pm by Allan Drury.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: 
| 
Print
| 
Email
